COVID-19 vaccines - Safety update: 8 September 2022
COVID-19 vaccines - Safety update: 8 September 2022
COVID-19 vaccines - Safety update: 8 September 2022
Referral: Pseudoephedrine-containing medicinal products, pseudoephedrine, Article 31 referrals, Recommendation provided by Pharmacovigilance Risk Assessment Committee, 01/12/2023
Ozempic / Victoza
Update on human variations web-based electronic application form implementation on product lifecycle management portal, Online, from 6 November 2023, 13:30 (CET) to 6 November 2023, 15:00 (CET)
Update on human variations web-based electronic application form implementation on product lifecycle management portal, Online, 13:30 - 15:00 Amsterdam time (CEST), from 06/11/2023 to 06/11/2023
Second European Medicines Agency (EMA) and EUCOPE bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 29 November 2023
Human medicines European public assessment report (EPAR): Plavix, clopidogrel, Stroke;Peripheral Vascular Diseases;Atrial Fibrillation;Myocardial Infarction;Acute Coronary Syndrome, Date of authorisation: 15/07/1998, Revision: 50, Status: Authorised
Second European Medicines Agency (EMA) and EUCOPE bilateral meeting, European Medicines Agency , from 29/11/2023 to 29/11/2023